Alzheimer and platelets: low-density platelet populations reveal increased serotonin content in Alzheimer type dementia.

[1]  M. Milovanovic,et al.  Alzheimer′s disease and granulocyte density diversity , 2013, European journal of clinical investigation.

[2]  Ying Li,et al.  Decreased mean platelet volume and platelet distribution width are associated with mild cognitive impairment and Alzheimer's disease. , 2013, Journal of psychiatric research.

[3]  M. Milovanovic,et al.  P-selectin paradox and dementia of the Alzheimer type: Circulating P-selectin is increased but platelet-bound P-selectin after agonist provocation is compromised , 2013, Scandinavian journal of clinical and laboratory investigation.

[4]  M. Milovanovic,et al.  Low-density platelet populations demonstrate low in vivo activity in sporadic Alzheimer disease , 2012, Platelets.

[5]  P. Järemo,et al.  Alzheimer’s disease is characterized by more low‐density erythrocytes with increased volume and enhanced β‐amyloid x‐40 content , 2011, Journal of internal medicine.

[6]  Alan J. Thomas,et al.  Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial , 2011, The Lancet.

[7]  M. Milovanovic,et al.  Platelet Density Distribution in Essential Thrombocythemia , 2010, Pathophysiology of Haemostasis and Thrombosis.

[8]  N. Pivac,et al.  Platelet serotonin concentration and monoamine oxidase type B activity in female patients in early, middle and late phase of Alzheimer's disease , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[9]  P. Järemo,et al.  Individual variations of platelet inhibition after loading doses of clopidogrel , 2002, Journal of internal medicine.

[10]  G. Lenzi,et al.  Amyloid precursor protein in platelets , 2001, Neurology.

[11]  D. Selkoe.  Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.

[12]  R. Rosenberg,et al.  Platelet APP isoform ratios correlate with declining cognition in AD , 2000, Neurology.

[13]  S. Israels,et al.  Platelet dense granules: structure, function and implications for haemostasis. , 1999, Thrombosis research.

[14]  K. Magyar,et al.  Platelet MAO-B Activity and Serotonin Content in Patients with Dementia: Effect of Age, Medication, and Disease , 1998, Neurochemical Research.

[15]  P. Järemo.  Computerised method for recording platelet density distribution , 1995, European journal of haematology.

[16]  T. Nakano,et al.  Epidemiological Survey of Dementia and Depression among the Aged Living in the Community in Japan , 1994, The Japanese journal of psychiatry and neurology.

[17]  P. Fischer,et al.  Depression in dementia of the Alzheimer type and in multi-infarct dementia. , 1990, The American journal of psychiatry.

[18]  J. Leysen,et al.  Evidence for functional 5-HT2 receptor sites on human blood platelets. , 1984, Biochemical pharmacology.

[19]  M. Milovanovic,et al.  Identification of low-density platelet populations with increased reactivity and elevated alpha-granule content. , 2003, Thrombosis research.

[20]  C. Caltagirone,et al.  Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. , 2002, Archives of neurology.

[21]  C. Eisdorfer,et al.  Peripheral serotonin in Alzheimer's disease. , 1995, Neuropsychobiology.

[22]  J. Sneddon,et al.  Blood platelets as a model for monoamine-containing neurones. , 1973, Progress in neurobiology.

[23]  Paasonen Mk.  Platelet 5-hydroxytryptamine as a model in pharmacology. , 1968 .